Zhang Xiaofan Reports New 5.6% Passive Stake in VYNE Therapeutics Inc.

On June 15, 2026, Zhang Xiaofan filed a Schedule 13G with the SEC, reporting a new 5.6% passive stake in VYNE Therapeutics Inc. (VYNE). The filing indicates that as of the event date on June 08, 2026, Zhang Xiaofan beneficially owns 1,873,388 shares of common stock. This position represents a significant increase from a previous holding of zero shares, marking a new major shareholder for the company. Zhang Xiaofan, a citizen of Hong Kong, China, maintains sole voting and dispositive power over all 1,873,388 shares. The filing was made under Rule 13d-1(c), certifying that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. VYNE Therapeutics Inc. is headquartered in Bridgewater, New Jersey, and the reporting person's principal residence is located in Shanghai, China. This transaction reflects a notable investment in the pharmaceutical company's $0.0001 par value common stock.